Induction of Tolerance in Solid Organ Transplantation: The Rationale to Develop Clinical Protocols in Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 2, 2009, Pages 603-606

  Donckier, V ^a   Sanchez Fueyo, A ^b   Craciun, L ^a   Lucidi, V ^a   Buggenhout, A ^a   Troisi, R ^c   Rogiers, X ^c   Bourgeois, N ^a   Boon, N ^a   Moreno, C ^a   Colle, I ^c   Van Vlierberghe, H ^c   de Hemptinne, B ^c   Goldman, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b HOSPITAL CLÍNIC   (Spain)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; THYMOCYTE ANTIBODY;

ARTICLE; CD8+ T LYMPHOCYTE; DRUG MECHANISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MEMORY CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LYMPHOCYTE DEPLETION; PRACTICE GUIDELINES AS TOPIC; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE;

EID: 62849101841     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.040     Document Type: Article

References (31)

1. Fishman J.A., and Rubin R.H. Infections in organ-transplant recipients. N Eng J Med 338 (1998) 1741
2. Dantal J., Hourmant M., Cantarovitch D., et al. Effect of long-term immunosuppression in kidney graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 351 (1999) 623
3. Kirk A.D. Ethics in the quest for transplant tolerance. Transplantation 77 (2000) 447
4. Calne R., and Davies H. Organ graft tolerance: the liver effect. Lancet 343 (1994) 67
5. Lerut J., and Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 6 (2006) 1774
6. Simpson N., Cho Y.W., Cicciarelli J.C., et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database. Transplantation 82 (2006) 1298
7. Devlin J., Doherty D., Thomson L., et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 27 (1998) 926
8. Martinez-Llordella P.-P.I., Orlando G., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7 (2007) 309
9. Alexander S.I., Smith N., Hu M., et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Eng J Med 358 (2008) 369
10. Starzl T.S., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361 (2003) 1502
11. Cosimi A.B., and Sachs D.H. Mixed chimerism and transplantation tolerance. Transplantation 77 (2004) 943
12. Fehr T., and Sykes M. Tolerance induction in clinical transplantation. Transplant Immunol 13 (2004) 117
13. Sayegh M.H., Fine N.A., Smith J.L., et al. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114 (1991) 954
14. Kadry Z., Mullhaupt B., Renner E.L., et al. Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. Transplantation 16 (2003) 1003
15. Kawai T., Cosimi A.B., Spitzer T.R., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Eng J Med 358 (2008) 353
16. Scandling J.D., Busque S., Dejbakhsh-Jones S., et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Eng J Med 358 (2008) 362
17. Donckier V., Troisi R., Le Moine A., et al. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl 12 (2006) 1523
18. Donckier V., Troisi R., Toungouz M., et al. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Transplant Immunol 13 (2004) 139
19. Shapiro R., Jordan M.L.J., Basu A., et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 238 (2003) 520
20. Swanson S.J., Hale D.A., Mannon R.B., et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 360 (2002) 1662
21. Kirk A.D., Hale D.A., Mannon R.B., et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76 (2003) 120
22. Calne R., Friend P., Moffatt S., et al. Prope tolerance, perioperative Campath-1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351 (1998) 1701
23. Pearl J.P., Parris J., Hale D.A., et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5 (2005) 465
24. Moxham V.F., Karegli J.K., Phillips R.E., et al. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 180 (2008) 3910
25. Oertel M., Sack U., Kohlhaw K., et al. Induction therapy including antithymocytes globulin induces marked alterations in T lymphocytes subpopulations after liver transplantation: results of a long-term study. Transpl Int 15 (2002) 463
26. Monti P., Scirpoli M., Maffi P., et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 118 (2008) 1806
27. Demirkiran A., Hendrikx T.K., Baan C.C., et al. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 85 (2008) 783
28. Segundo D.S., Ruiz J.C., Izquierdo M., et al. Calcineurin inhibitors, but not rapamycin, reduces percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipeints. Transplantation 82 (2006) 550
29. Noris M., Casiraghi F., Todeschini M., et al. Regulatory T cells and T cell depletion: The role of immunosuppressive drugs. J Am Soc Nephrol 18 (2007) 1007
30. Immune Tolerance Network. www.immunetolerance.org
31. RISET: Reprogramming the Immune System for Establishment of Tolerance. www.risetfp6.org